Aprea Therapeutics Inc (APRE)
5.35
+0.18
(+3.48%)
USD |
NASDAQ |
Apr 25, 16:00
5.35
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0163M |
| June 30, 2021 | -0.0156M |
| March 31, 2021 | -0.0135M |
| December 31, 2020 | -0.0257M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.0239M |
| June 30, 2020 | -0.0349M |
| March 31, 2020 | -0.0431M |
| December 31, 2019 | -0.0309M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.0431M
Minimum
Mar 2020
--
Maximum
Dec 2021
-0.0227M
Average
-0.0239M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
| NeuBase Therapeutics Inc | -0.0548M |
| Stoke Therapeutics Inc | 105.95M |
| Processa Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |